Mammalian development is promoted by a progressive rise in circulating levels of triiodothyronine (T3) and thyroxine (T4), a tetra-iodinated precursor of T3. However, tissues respond to T3 in distinct ways and with different time courses. This individualized response may be determined partly in the tissue itself by the amplification or depletion of T3 levels by type 2 and type 3 deiodinases, respectively ([@B1]). Type 2 deiodinase (encoded by *Dio2*) converts T4 into T3 by outer ring 5′-deiodination whereas type 3 deiodinase (encoded by *Dio3*) depletes T4 and T3 by inner ring 5-deiodination, producing reverse T3 and 3,3′-diiodothyronine, respectively.

The functions of the *Dio3* gene include a prominent role in sensory development. *Dio3*^−/−^ mice lose retinal cones, the photoreceptors that mediate daylight vision and color vision ([@B5]) and represent a model for achromatopsia, a form of retinal degeneration with loss of cone function ([@B6]). *Dio3*^−/−^ mice also exhibit deafness and premature cochlear differentiation, suggesting a protective role for type 3 deiodinase during auditory development ([@B7]). Additionally, *Dio3*^−/−^ mice display retarded growth and an atrophic thyroid gland with abnormal T4 and T3 levels, reflecting defects in the pituitary--thyroid axis and in the systemic thyroid hormone status ([@B8]). *Dio2*^−/−^ mice exhibit a different array of phenotypes, including moderately elevated T4 levels and impaired negative feedback by T4 over the pituitary--thyroid axis ([@B10]). *Dio2*^−/−^ mice also display deafness with cochlear retardation similar to that caused by hypothyroidism, despite having circulating T4 and T3 levels that would normally suffice for the development of hearing ([@B12]).

The opposing activities of type 2 and type 3 deiodinases suggest that their net action may be a key determinant of development. This composite action is likely to be dynamic given the shifting, or reciprocal, patterns of expression of these deiodinases in many immature tissues ([@B1]), including the cochlea ([@B7]). The net action may also involve a role in setting levels of T4 and T3 in the circulation, which may further modify tissue outcomes. To test whether the *Dio2* and *Dio3* genes counteract each other in development, we investigated whether deletion of *Dio2* reverses or otherwise modifies visual and auditory phenotypes in *Dio3*^−/−^ mice.

Materials and Methods {#s1}
=====================

Mouse strains {#s2}
-------------

Strains carrying *Dio2* ([@B10]) and *Dio3* ([@B8]) knockout alleles were crossed to generate wild-type (WT), *Dio2*^−/−^, *Dio3*^−/−^, and *Dio2*^−/−^;*Dio3*^−/−^ groups on a similar genetic background (C57BL/6J × 129/Sv). *Dio3*^+/−^;*Dio2*^+/−^ parents were crossed to generate groups for analyses. Genotyping was determined by polymerase chain reaction (PCR) as described ([@B8]). Studies on mice followed American Thyroid Association guidelines ([@B16]) and approved protocols at the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. Most results are presented for mixed groups of males and females, unless otherwise noted. The low survival rates of *Dio3*^−/−^ pups ([@B8]) and the complex breeding scheme necessary to generate requisite genotypes made it impractical in most cases to obtain sufficient numbers for groups of only one gender. There were no obvious gender-based differences in the phenotypes examined. For serum hormones in adults, separate male and female groups are presented.

Immunohistochemistry and *in situ* hybridization {#s3}
------------------------------------------------

Eyes were dissected and fixed in 4% paraformaldehyde/phosphate-buffered saline (PBS) for 3 to 5 hours at 4°C, then rinsed in PBS, cryoprotected in 30% sucrose, and embedded in OCT. For immunostaining for opsins or activated caspase 3, 10-μm-thick cryosections were incubated overnight with primary antibody in PBS with 1.5% normal goat or horse serum, 0.1% bovine serum albumin, and 0.4% Triton X-100, as described ([@B5]). Sections were rinsed in PBS then incubated with second antibody for color development (Vector Laboratories, Burlingame, CA) or with Alexa Fluor 488 goat anti-rabbit or anti-mouse secondary antibody for immunofluorescence. For *in situ* hybridization, eyes were fixed in 4% paraformaldehyde/PBS overnight. Cryosections were incubated with digoxigenin-labeled riboprobes made from a mouse *Dio2* complementary DNA (cDNA), spanning bases 590 to 1383 downstream of the ATG start codon, as described ([@B12]). For antibodies used, see [Table 1](#T1){ref-type="table"}.

###### 

**Antibodies Used**

  **Antibody**                 **Peptide/Protein Target**   **Species**   **Type**     **Manufacturer**           **Catalog No.**   **Dilution**   **RRID**
  ---------------------------- ---------------------------- ------------- ------------ -------------------------- ----------------- -------------- ------------
  Anti--S opsin                S opsin                      Goat          Polyclonal   Santa Cruz Biotechnology   Sc-14363          1:1000         AB_2158332
  Anti--M opsin                M opsin                      Rabbit        Polyclonal   Millipore                  AB 5405           1:1000         AB_177456
  Anti--activated caspase 3    Caspase 3                    Rabbit        Polyclonal   Promega                    G748A             1:300          AB_430875
  Anti--glutamine synthetase   Glutamine synthetase         Mouse         Monoclonal   Millipore                  MAB302            1:300          AB_2110656

Abbreviation: RRID, Research Resource Identifier.

RNA analysis {#s4}
------------

RNA sequencing datasets represent pools of six to 12 retinae from WT mice (of mixed C57BL/6J × 129/Sv background) at the stages shown in [Fig. 1](#F1){ref-type="fig"}. An independent analysis on a separate series of samples \[at embryonic day 17, postnatal day (P)6, and P14\] gave similar results. Total RNA was prepared using TRIzol reagent and messenger RNA (mRNA) enriched using a Dynabeads purification kit (Thermo Fisher, Grand Island, NY). cDNA was synthesized using a SuperScript double-strand cDNA kit (Thermo Fisher) then fragmented with a Bioruptor (Diagenode, Danville, NJ) with medium output settings for 15 minutes. Libraries were constructed using a TruSeq chromatin immunoprecipitation library preparation kit (Illumina, San Diego, CA). Fifty base single-end reads were generated on an Illumina HiSeq 2500 sequencer, and prealignment of data was performed at the National Institute of Diabetes and Digestive and Kidney Diseases Genomics Facility and further analyzed using a Genomatix (Munich, Germany) platform. Data were converted using bcl2fastq software version 2.17.1.14 (Illumina). After chastity filtering, alignment was performed using BBMap version 36.02 to mouse MM9 reference genome. The accession number for the WT retina datasets on the Gene Expression Omnibus database is GSE95016.

![Expression of the *Dio2* gene in mouse retina. (a) Analysis of *Dio1*, *Dio2*, and *Dio3* mRNA expression in WT mice by RNA sequencing. Data points represent pools of retinae. RPKM, reads per kilobase of transcript per million mapped reads. (b) Outer ring 5′-deiodination in pooled tissue homogenates from WT and *Dio2*^−/−^ mice, measured using T4 substrate. The level of 5′-deiodination in eye or retina was low compared with cochlea at P8. \**P* \< 0.05, \*\**P* \< 0.001 (by Student *t* test), comparing *Dio2*^−/−^ to WT. (c) RT-PCR detection of *Dio2* mRNA in retina from WT but not *Dio2*^−/−^ mice at P28; *Gapdh*, positive control gene. Product bands were 500 bp. The *Dio2* product resided within the deleted sequences in *Dio2*^−/−^ mice. (d) *In situ* hybridization detected *Dio2* mRNA \[antisense probe (as)\] in the inner nuclear layer in WT but not in *Dio2*^−/−^ mice. A sense probe gave minimal nonspecific signal. (e) Confocal images showing *Dio2* signals detected by *in situ* hybridization (gray) and glutamine synthetase (GS) detected by immunofluorescence (turquoise), a marker of Müller glial cells. The overlay shows alignment of GS^+^ and *Dio2*^+^ cells (arrowheads). E, embryonic day; GCL, ganglion cell layer; INL, inner nuclear layer; ipl, inner plexiform layer; is/os, inner and outer segments; ONL, outer nuclear layer; opl, outer plexiform layer.](en.2017-00055f1){#F1}

For reverse transcription polymerase chain reaction (RT-PCR), cDNA was made from retinal RNA from WT and *Dio2*^−/−^ male mice at P28. Analysis of *Dio2* and *Gapdh* genes was performed with primers as follows: *Dio2* forward, 5′-CAG GTA ACA ATT ATG CCT CGG-3′, reverse, 5′-GCT GAA ATT CTT CTC CAG CCA AAC-3′; *Gapdh* forward, 5′-TCG GTG TGA ACG GAT TTG GCC GTA-3′, reverse, 5′-ATG GAC TGT GGT CAT GAG CCC TTC-3′. Both product bands were 500 bp.

Histology {#s5}
---------

Eyes were fixed in 2% paraformaldehyde/3% glutaraldehyde in PBS for 24 hours. The lens was removed and then the retina was rinsed in PBS and dehydrated in an ethanol gradient before embedding in glycol methacrylate plastic ([@B5]); 3-μm-thick microtome sections were stained with Gill no. 3 hematoxylin with eosin. Cochleae were fixed for 1 to 2 days, then decalcified in 0.1 M EDTA for 1 week before embedding in plastic; 4-μm-thick sections were stained with Gill no. 3 hematoxylin. Thyroid glands were fixed for 3 to 5 days, then immersed in 0.1 M EDTA for 1 week to soften the attached trachea before embedding in plastic; 6-μm-thick sections were stained with Gill no. 3 hematoxylin with eosin. Areas of the gland and follicles were measured using ImageJ and are expressed as arbitrary units (1 unit = 12.3 μm^2^) for five sections per gland for three to four mice. Cone and rod nuclei were counted in 208-μm-long fields of the outer nuclear layer, on three to four sections per mouse for three mice.

Auditory and visual tests {#s6}
-------------------------

Adult mice (2 to 4 months of age) were anesthetized with avertin (0.25 mg/g body weight) for testing the auditory-evoked brainstem response (ABR) using a SmartEP system (Intelligent Hearing Systems, Miami, FL) as described ([@B7]). Amplitudes of the first peak to the following trough were measured by the SmartEP system. Adult mice (2 months of age) were anesthetized with ketamine and xylazine for measurement of the electroretinogram (ERG) for light-adapted, photopic cone responses and dark-adapted, scotopic rod responses using an Espion electrophysiology system (Diagnosys, Lowell, MA), as described ([@B17]). For dark adaptation, mice were housed overnight (∼18 hours) in darkness.

Statistical analysis {#s7}
--------------------

Statistical significance between several genotype groups was determined by one-way analysis of variance (ANOVA) and a Tukey *post hoc* test using GraphPad Prism software. A Student *t* test was used for other two group comparisons.

Deiodination assays and hormone measurements {#s8}
--------------------------------------------

Assays for type 2 deiodination activity and for T3 and T4 levels were performed as described ([@B8]). Pools of dissected eyes, retinae, or cochleae were homogenized in buffer containing 20 mM Tris-HCl (pH 7.6), 5 mM dithiothreitol, and 0.25 mM sucrose. Pools of four to six eyes, six to 10 retinae, and 8 cochleae were analyzed in triplicate. Homogenates were incubated with \[^125^I\]T4 substrate, 1.2 mM EDTA, 1 mM propylthiouracil, 1 μM T3, and 20 mM dithiothreitol for 1 hour at 37°C, and then products were separated using Bio-Rad AG 50WXG (H^+^) resin to measure \[^125^I\]I^−^ product. Serum total T4 and T3 values were determined by radioimmunoassay using Coat-A-Count reagents (Diagnostic Systems Laboratories, Webster, TX), as described ([@B8]). Hormones were measured for individual adult mice and for pools of two to three pups due to limited volumes of serum obtained.

Results {#s9}
=======

*Dio2* expression in mouse retina {#s10}
---------------------------------

Given the role of type 3 deiodinase in cone photoreceptor function ([@B5]), we further investigated type 2 deiodinase in the retina in mice. RNA sequencing analysis revealed rising levels of *Dio2* mRNA in the postnatal retina \[[Fig. 1(a)](#F1){ref-type="fig"}\]. *Dio3* mRNA displayed an earlier peak, as expected ([@B5]), suggesting a reciprocal developmental profile for *Dio3* and *Dio2* expression. Little or no *Dio1* mRNA (type 1 deiodinase) was detected at any stage.

Type 2 5′-deiodination activity was detected in homogenates of WT mouse eye or dissected retina at postnatal ages \[[Fig. 1(b)](#F1){ref-type="fig"}\]. This activity was attributed to type 2 deiodinase because the activity was abrogated in *Dio2*^−/−^ mice and was resistant to inhibition by propylthiouracil, thereby distinguishing it from type 1 deiodinase activity. The type 2 deiodination activity in the eye or retina was low compared with that in the cochlea at P8, a known enriched source of type 2 deiodinase in mice ([@B15]). RT-PCR analysis also detected *Dio2* mRNA in retina in WT mice but not in *Dio2*^−/−^ mice \[[Fig. 1(c)](#F1){ref-type="fig"}\].

*In situ* hybridization detected *Dio2* mRNA in the postnatal retina in the inner nuclear layer \[[Fig. 1(d)](#F1){ref-type="fig"}\], which contains several types of interneurons and Müller glia. A specific *Dio2* signal was not detected on sections from *Dio2*^−/−^ mice, which lack the portion of the gene used as a probe for *in situ* hybridization ([@B12]). The *Dio2* signal was weak but localized to an irregular band of cells in a central zone of the inner nuclear layer, suggestive of expression in Müller glia. This proposal was supported by double staining for glutamine synthetase, a marker of Müller glia \[[Fig. 1(e)](#F1){ref-type="fig"}\].

Rescue of cone photoreceptors in *Dio3^−/−^;Dio2^−/−^* mice {#s11}
-----------------------------------------------------------

To test whether deletion of *Dio2* resulted in cone defects or modified the phenotype in *Dio3*^−/−^ mice, we examined opsin expression. Most mammals express two cone opsin photopigments with peak sensitivity to medium-long (M, or green) and short (S, or blue) wavelengths of light ([@B19]). In WT mice, opsins are distributed in gradients: M opsin predominates in cones in the superior retina, and S opsin predominates in the inferior retina \[[Fig. 2(a)](#F2){ref-type="fig"} and [2(b)](#F2){ref-type="fig"}\]. *Dio3*^−/−^ adult mice lacked most cones of both M and S types ([@B5]), but *Dio2*^−/−^ mice displayed no obvious opsin abnormality. However, *Dio3*^−/−^;*Dio2*^−/−^ mice recovered M and S opsin expression compared with *Dio3*^−/−^ mice \[[Fig. 2(c)](#F2){ref-type="fig"}\]. The opsin gradient was slightly exaggerated in *Dio3*^−/−^;*Dio2*^−/−^ mice: M opsin was poorly restored in inferior regions, and S opsin was poorly restored in superior regions, suggesting that although cones were rescued, opsin patterning was not fully normal in the absence of both deiodinases.

![Immunohistochemistry for cone opsins in deiodinase-deficient mice. (a) Diagram of a vertical section through the eye depicting the superior and inferior views of the retina shown in (b). The retina is gray-shaded at the back of the eye. (b) In WT mice at 2 months of age, M opsin predominates in cones in superior (sup) and S opsin in inferior (inf) regions of the retina (arrowheads indicate stained cone segments). *Dio3*^−/−^ mice lack both cone types, but *Dio3*^−/−^;*Dio2*^−/−^ mice regain many M and S cones. IS/OS, inner and outer segments; ONL, outer nuclear layer. (c) Counts of M and S opsin--positive cones. Groups contained three mice. ANOVA was performed for all genotypes. \*\**P* \< 0.01, \*\*\**P* \< 0.001, for comparisons of mutant genotypes to WT; ^\#^*P* \< 0.05, ^\#\#\#^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^.](en.2017-00055f2){#F2}

Histological analysis corroborated the recovery of cones in *Dio3*^−/−^;*Dio2*^−/−^ mice. In mice, ∼3% of photoreceptors are cones and ∼97% are rods, the photoreceptor type that mediates vision in dim light ([@B20]). Cones are distinguished by their location at the edge of the outer nuclear layer and by their large nuclei compared with rods, which have small, dense nuclei \[[Fig. 3(a)](#F3){ref-type="fig"}\]. In *Dio3*^−/−^;*Dio2*^−/−^ mice, cone nuclei attained ∼70% of WT numbers \[[Fig. 3(b)](#F3){ref-type="fig"}\]. *Dio2*^−/−^ mice displayed normal numbers of cone and rod nuclei. *Dio3*^−/−^ and *Dio3*^−/−^;*Dio2*^−/−^ genotypes both displayed a modest loss of rods (∼12% below WT), suggesting a minor vulnerability of rods in these genotypes.

![Retinal histology in deiodinase-deficient adult mice. (a) Cones (arrowheads) are distinguished by their large nuclei and location in the outer zone of the outer nuclear layer on plastic sections. In contrast, the more numerous rods \[representative rod (r)\] have small, dense nuclei and reside throughout the outer nuclear layer. Adult mice at 2 to 3 months of age are shown. (b) Cone and rod nuclei counted in outer nuclear layer fields on 3-μm-thick plastic sections (n = 3 mice, mean ± SEM). *Dio3*^−/−^ mice have a major loss of cones and minor loss of rods. *Dio3*^−/−^;*Dio2*^−/−^ mice recover many cones. ANOVA was performed for all genotypes. \*\**P* \< 0.01, \*\*\**P* \< 0.001, for comparisons of mutant genotypes to WT; ^\#\#\#^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^. IS/OS, inner and outer segments; INL, inner nuclear layer; ONL, outer nuclear layer.](en.2017-00055f3){#F3}

Cell death in the postnatal retina {#s12}
----------------------------------

In *Dio3*^−/−^ mice, cones degenerate by apoptosis in the postnatal period ([@B5]), as demonstrated by staining for activated caspase 3 \[[Fig. 4(a)](#F4){ref-type="fig"}\]. In WT pups, a modest incidence of apoptosis occurs with a peak at ∼P2 and then a decline to low levels during the next 2 weeks ([@B21]). Apoptotic cells appear in shifting patterns in neonatal mice, as many immature cell types have not yet reached their final location. Cones migrate inward through the neuroblast layer and then outward to the outer zone of the outer nuclear layer as the retina matures ([@B22]). At P2, *Dio3*^−/−^;*Dio2*^−/−^ mice displayed fewer caspase 3--positive cells in the neuroblast layers than do *Dio3*^−/−^ mice ([Fig. 4](#F4){ref-type="fig"}). In *Dio2*^−/−^ mice, caspase 3--positive cell numbers were in the normal range.

![Apoptosis in the retina in deiodinase-deficient mice. (a) In the postnatal retina, cells positive for activated caspase 3 \[caspase 3(+)\] occur with moderate incidence in WT mice and with a higher incidence in *Dio3*^−/−^ mice that is reduced in *Dio3*^−/−^;*Dio2*^−/−^ mice. (b) Caspase 3(+) cell counts (mean ± SEM) determined in retinal layers at P2 and P14. ANOVA was performed for all genotypes. \*\**P* \< 0.01, \*\*\**P* \< 0.001, for comparisons of mutant genotypes to WT; ^\#^*P* \< 0.05, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^. GCL, ganglion cell layer; ONBL/INBL, outer and inner neuroblast layers; ONL/INL, outer and inner nuclear layers.](en.2017-00055f4){#F4}

ERG analysis {#s13}
------------

*Dio3*^−/−^ mice display a defective cone ERG in response to photopic stimuli at 520 nm and 360 nm ([@B5]), wavelengths that optimally activate M and S opsins, respectively, in mice ([@B23]) \[[Fig. 5(a)](#F5){ref-type="fig"}\]. *Dio2*^−/−^ mice had normal responses at both wavelengths. However, compared with *Dio3*^−/−^ mice, *Dio3*^−/−^;*Dio2*^−/−^ mice recovered substantial responses at both wavelengths, and the ERG b-wave magnitudes approached normal over a range of stimulus intensities \[[Fig. 5(b)](#F5){ref-type="fig"}\].

![ERG analysis in deiodinase-deficient mice. (a) Representative traces for cone (upper two rows) and rod ERG (lower row) in 2- to 3-month-old mice. Photopic stimuli at 520 nm (green) and 360 nm (blue) wavelengths indicate M and S opsin responses, respectively. Cone traces are shown for five intensities: 1.26, 2.51, 5.011, 10, and 38 (P) cd⋅s/m^2^ at 520 nm, and 0.00032, 0.001, 0.0032, 0.01, and 0.0316 (P) cd⋅s/m^2^ at 360 nm. Rod traces are for intensities of 0.0001, 0.000316, 0.001, 0.0063, and 0.01 (P) cd⋅s/m^2^. (b) Magnitude of the ERG b-wave for a range of stimulus intensities (mean ± SEM) for cones (upper two plots) and rods (lower plot). Most groups included 10 to 12 mice; the *Dio3*^−/−^ group included four mice. For *Dio3^−/−^;Dio2^−/−^* mice, the magnitude differed from *Dio3^−/−^* mice (*P* \< 0.01) for intensities \>4 cd⋅s/m^2^ at 520 nm and \>0.0018 cd⋅s/m^2^ at 360 nm. For rods, magnitudes are different from WT for each mutant genotype for intensities \>0.00063 cd⋅s/m^2^ (*P* \< 0.01).](en.2017-00055f5){#F5}

We observed a reduced rod ERG in *Dio3*^−/−^ mice as expected ([@B5]) and in *Dio2*^−/−^ mice, suggesting that rod function was modestly impaired in the absence of either type 3 or type 2 deiodinase. In *Dio3*^−/−^;*Dio2*^−/−^ mice, the rod b-wave magnitude was somewhat increased compared with *Dio3*^−/−^ mice and approached the level in *Dio2*^−/−^ mice.

ABRs {#s14}
----

Both *Dio3*^−/−^ and *Dio2*^−/−^ mouse strains exhibit deafness with a defective ABR ([@B7]). Given that both deiodinases are expressed in the immature cochlea, we tested whether deletion of *Dio2* would ameliorate auditory defects in *Dio3*^−/−^ mice. In *Dio3*^−/−^ and *Dio2*^−/−^ adult mice, auditory thresholds were elevated for a click (broadband frequency) stimulus \[[Fig. 6(a)](#F6){ref-type="fig"}\]. Thresholds were 68 ± 5 and 76 ± 3 dB sound pressure level (SPL) for *Dio3*^−/−^ and *Dio2*^−/−^ genotypes, respectively, and 46 ± 2 dB SPL for WT \[mean ± standard error of the mean (SEM)\] \[[Fig. 6(a)](#F6){ref-type="fig"}\]. However, in *Dio3*^−/−^;*Dio2*^−/−^ mice, the threshold was 97± 2 dB SPL, worse than for either single mutant (*P* \< 0.001). *Dio3*^−/−^;*Dio2*^−/−^ mice displayed similarly exacerbated defects in response to pure tone stimuli at 8, 16, and 32 kHz frequencies that span the sensitive range of hearing in mice (not shown).

![ABR in deiodinase-deficient mice. (a) Mean thresholds (±SEM) for a click stimulus for adult mice (2 to 3 months old); numbers are noted within columns. The threshold was further elevated in *Dio3*^−/−^;*Dio2*^−/−^ mice compared with *Dio3*^−/−^ or *Dio2*^−/−^ mice. ANOVA was performed for all genotypes. \*\*\**P* \< 0.001, for comparisons of mutants to WT; ^\#\#\#^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^; ^§§§^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio2*^−/−^. (b) Representative ABR traces in response to a click stimulus at intensities noted on the left. A typical WT waveform shows three to four major peaks within 5 ms of the stimulus. Thresholds are underlined. No specific waveform was detected for the *Dio3*^−/−^;*Dio2*^−/−^ mice. Vertical bar indicates response scale (μV). Note the higher thresholds and diminished responses for *Dio3*^−/−^ and *Dio2*^−/−^ mice. (c) Amplitude of waveforms (peak 1 to following trough) evoked with a click applied at equal intensity (90 dB SPL) for each genotype. ANOVA was performed for all genotypes. \*\*\**P* \< 0.001, for comparisons of mutant genotypes to WT; ^\#\#\#^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^; ^§§§^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio2*^−/−^.](en.2017-00055f6){#F6}

[Figure 6(b)](#F6){ref-type="fig"} shows representative waveform traces with three to four peaks detected within 5 ms of the stimulus in WT mice. In contrast, in many *Dio3*^−/−^;*Dio2*^−/−^ mice, no specific peaks could be evoked even with a maximal stimulus at 100 dB SPL. The waveforms that were evoked in the single mutant strains displayed significantly lower magnitudes than in WT mice when subjected to equivalent stimuli \[[Fig. 6(c)](#F6){ref-type="fig"}\].

Cochlear morphology {#s15}
-------------------

The cochlear abnormalities in *Dio3*^−/−^ ([@B7]) and *Dio2*^−/−^ ([@B12]) mice suggest that type 3 deiodinase constrains and type 2 deiodinase stimulates the rate of postnatal cochlear remodeling prior to the onset of hearing (at ∼P13). In WT mice at P9, the organ of Corti, which contains the mechanosensory hair cells, approaches a nearly mature morphology with three rows of outer hair cells and one row of inner hair cells on either side of an open tunnel of Corti \[[Fig. 7(a)](#F7){ref-type="fig"}\]. The hair cells are elongated above the Deiters support cells, and the greater epithelial ridge, a transient cell-dense structure, has largely regressed to form the inner sulcus cavity below the tectorial membrane. The tectorial membrane extends to the hair cells and is essential for auditory transduction ([@B24]). The morphological status of the organ of Corti in *Dio3*^−/−^ pups is accelerated in the first few neonatal days, but by P9, it appears relatively normal whereas in *Dio2*^−/−^ pups, the morphology is retarded. In *Dio2*^−/−^ pups, the greater epithelial ridge displayed only initial signs of regression, the hair cells lacked an upright structure, the tunnel of Corti was unopened, and the tectorial membrane was enlarged. *Dio3*^−/−^;*Dio2*^−/−^ mice displayed a similar retardation as in *Dio2*^−/−^ mice. Thus, deletion of *Dio2* resulted in retardation or over-reversal rather than correction of the *Dio3*^−/−^ phenotype.

![Cochlear histology in deiodinase-deficient mice. (a) At P9, a few days before hearing begins in WT mice, the organ of Corti is not fully mature but displays an open tunnel of Corti (tc) between the inner pillar (ip) and outer pillar (op) cells. The inner and outer hair cells (gray-filled and open arrowheads, respectively) are elongated, and the inner sulcus (is) is open beneath the tectorial membrane (tm). Morphology is similar in WT and *Dio3*^−/−^ mice, but in *Dio2*^−/−^ and *Dio3*^−/−^;*Dio2*^−/−^ genotypes it is retarded: the tunnel of Corti has not opened (black arrow), the hair cells have not elongated, the inner sulcus is only partly open (\*), many cells remain in the greater epithelial ridge (ger), and the tectorial membrane is enlarged (gray arrow). (b) In adults (2 to 3 months old), the morphology in *Dio2*^−/−^ and *Dio3*^−/−^;*Dio2*^−/−^ genotypes has largely caught up with that in WT and *Dio3*^−/−^ mice, but the tectorial membrane remains enlarged.](en.2017-00055f7){#F7}

In adults, the morphology in *Dio3*^−/−^;*Dio2*^−/−^ mice still resembled that in *Dio2*^−/−^ mice: in both genotypes, overall morphology had caught up with that in WT mice but the tectorial membrane was persistently enlarged.

Thyroid hormones and thyroid gland morphology {#s16}
---------------------------------------------

In addition to defects in the retina and cochlea, *Dio2*^−/−^ ([@B10]) and *Dio3*^−/−^ ([@B8]) mice have abnormalities in systemic T4 and T3 levels that could contribute to phenotypes. Therefore, we investigated whether deletion of both genes in *Dio3*^−/−^;*Dio2*^−/−^ mice modified serum levels of T4 and T3. *Dio3*^−/−^ pups are known to exhibit an extreme phenotype of undetectable T4 and high T3 ([@B8]), but in *Dio3*^−/−^;*Dio2*^−/−^ pups at P5, T4 was increased and T3 decreased to approximately normal ranges \[[Fig. 8(a)](#F8){ref-type="fig"}\]. *Dio2*^−/−^ pups had a high T4 level, as expected from previous evidence at juvenile ages ([@B10]).

![Thyroid hormone levels and thyroid gland histology. (a) In pups at P5, serum T4 was undetectable in *Dio3*^−/−^ pups, but in *Dio3*^−/−^;*Dio2*^−/−^ pups it was similar to WT. T3 was high in *Dio3*^−/−^ pups, but in *Dio3*^−/−^;*Dio2*^−/−^ pups it was similar to WT. Numbers of pools of serum (males and females) tested are noted within columns (or above column for T4, *Dio3*^−/−^). Pools contained males and females because of scarcity of the *Dio3*^−/−^ genotype in the litters, as explained in *Materials and Methods*. ANOVA was performed for all genotypes. \*\**P* \< 0.01, \*\*\**P* \< 0.001, for comparisons of mutant genotypes to WT; ^\#\#\#^*P* \< 0.001, for comparisons of *Dio3*^−/−^;*Dio2*^−/−^ to *Dio3*^−/−^. (b) In 2- to 3-month-old adults, T4 is lower in *Dio3*^−/−^ mice than in WT (males, \*\**P* \< 0.01); in females, T4 is lower but not significantly. In *Dio3*^−/−^;*Dio2*^−/−^ mice, T4 is elevated compared with *Dio3*^−/−^ mice (^\#^*P* \< 0.05 in males). Number of mice is noted within columns. (c) In *Dio3*^−/−^ mice (2 to 3 months old), the thyroid gland is small and has many atrophic follicles. In *Dio3*^−/−^;*Dio2*^−/−^ mice, the gland has a near normal size. (d) Areas of a thyroid gland lobe or follicle are smaller in *Dio3*^−/−^ than in WT mice (mean ± SEM) but they have near normal dimensions in *Dio3*^−/−^;*Dio2*^−/−^ mice. Number of mice is noted within columns. Groups included males and females, except the *Dio2*^−/−^ group, which included only males; no differences were obvious between males and females. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, compared with WT; ^\#\#^*P* \< 0.01, ^\#\#\#^*P* \< 0.001, *Dio3*^−/−^;*Dio2*^−/−^ compared with *Dio3*^−/−^.](en.2017-00055f8){#F8}

By weaning and adult ages, *Dio3*^−/−^ mice eventually acquire detectable levels of T4, although still below normal, whereas T3 drops to subnormal levels ([@B8]). *Dio2*^−/−^ mice retain slightly high T4 beyond weaning age ([@B10]). In *Dio3*^−/−^;*Dio2*^−/−^ mice at 2 to 3 months of age, both T4 and T3 were in the normal range \[[Fig. 8(b)](#F8){ref-type="fig"}\], suggesting a persistent stabilization of T4 and T3 levels in the circulation.

In *Dio3*^−/−^;*Dio2*^−/−^ mice, the thyroid gland recovered a more normal size and follicular content than did the atrophic gland in *Dio3*^−/−^ mice ([@B8]) \[[Fig. 8(c)](#F8){ref-type="fig"} and [8(d)](#F8){ref-type="fig"}\]. In *Dio2*^−/−^ mice, the gland was slightly enlarged. In WT or *Dio3*^−/−^;*Dio2*^−/−^ mice, most follicles (69% and 62%, respectively) were medium-sized (100 to 200 area units) or larger. In contrast, in *Dio3*^−/−^ mice, most follicles (70%) were small (\<100 area units), and only 30% were medium-sized or larger. In *Dio2*^−/−^ mice, the distribution of follicle sizes resembled that in WT mice. The results indicate counteracting roles for *Dio3* and *Dio2* genes in determining thyroid gland morphology and systemic levels of T4 and T3.

Developmental weight gain {#s17}
-------------------------

*Dio3*^−/−^;*Dio2*^−/−^ mice thrived reasonably well and gained more weight than *Dio3*^−/−^ mice at juvenile ages ([@B8]). At 5 weeks of age, weights of WT and *Dio3*^−/−^ males were 18.5 ± 1.7 and 11.5 ± 3.7 g, respectively (mean ± SEM; n = 7; *P* \< 0.001). *Dio3*^−/−^;*Dio2*^−/−^ males weighed 15.3 ± 2.6 g, representing a 30% improvement compared with *Dio3*^−/−^ males (n = 10, *P* = 0.01). Recovery of weight continued into adulthood. Young females displayed similar trends, but after 5 weeks of age, both *Dio3*^−/−^;*Dio2*^−/−^ and *Dio3*^−/−^ genotypes were of similar weight, and neither was significantly different than WT female mice (n = 6, *P* = 0.9).

Discussion {#s18}
==========

This study shows that deletion of *Dio2* strongly modifies phenotypes in *Dio3*^−/−^ mice and supports the proposal that the composite action of both type 2 and type 3 deiodinases is critical for mammalian development. We suggest that such combined action offers enhanced control over T3 functions in sensitive tissues during development. The outcomes vary between tissues and may involve both direct and indirect influences to different extents at distinct stages, as discussed later.

Retinal photoreceptors {#s19}
----------------------

T3 controls the differentiation and survival of cone photoreceptors. The expression of M opsin and the patterning of M and S opsins over the retina depend on a cone-specific thyroid hormone receptor ([@B25]) and adequate T3 and T4 in the circulation ([@B26]). However, an excess of T3 or deletion of *Dio3* leads to cone cell death, indicating that the T3 signal must also be appropriately constrained ([@B5]). Our findings on the *Dio2* gene suggest a possible additional need for amplification of T3 in the postnatal retina.

A role for type 2 deiodinase in the mammalian retina was implied by an earlier report of outer ring deiodination activity in the rat retina ([@B30]). In the postnatal mouse retina, we detected type 2 deiodination, although at low levels. *In situ* hybridization localized *Dio2* mRNA in Müller glial cells, in agreement with a report that mentioned detection of *Dio2* mRNA by microarray analysis in flow-sorted Müller cells ([@B31]). Moreover, we detected little or no *Dio2* mRNA in isolated cones and rods (unpublished data), cell types that constitute ∼70% of the retinal cell population. These findings suggest similarities between the retina and the brain, in which *Dio2* is expressed mostly in glia rather than neurons ([@B32]). Müller glial projections span the layers of the retina from the outer limiting membrane to the inner surface of the ganglion cell layer and form an interface with the vasculature that provides homeostatic support for photoreceptors and other retinal neurons ([@B33]). Thus, in addition to their role in intercellular transfer of ions and metabolites, Müller glia may form part of a cellular pathway for transfer of T3 in the retina.

*Dio2*^−/−^ mice had no overt cone defects but did have a moderately impaired rod ERG, suggesting a subtle role for type 2 deiodinase on rod function. We previously noted a reduced rod ERG in *Dio3*^−/−^ mice ([@B5]). We cannot exclude a subtle role for type 2 deiodinase on nonphotoreceptor cell types or on nondevelopmental processes such as aging. However, the major impact of deletion of *Dio2* was revealed in *Dio3*^−/−^ mice, which resulted in rescue of cones. This rescue potentially reflects adjustments both of locally generated T3 in the retina and of the high systemic T3 levels that occur in young *Dio3*^−/−^ mice. Future investigation of these possibilities may be aided by cell-specific deletions of *Dio2* and *Dio3* genes.

A *Dio2* knockout in zebrafish ([@B34]) reduced the size of the eye and ear, suggesting a conserved role for the *Dio2* gene in these sensory organs. Knockdown of *Dio2* or *Dio3* in zebrafish also delayed growth of the eye, delayed opsin expression, and partially disorganized the retinal layers ([@B35]). Both *Dio2* and *Dio3* genes are also expressed in the chick embryonic retina ([@B36]), suggesting that a composite action by both enzymes in the retina may be widely conserved.

The recovery of cones in *Dio3*^−/−^ mice following the deletion of *Dio2* may have wider implications for retinal degeneration and loss of vision ([@B37]). Most known forms of retinal degeneration do not result from defective T3 signaling, although a high free T4 level in adult human populations has been associated with an increased risk of age-related macular degeneration ([@B38]), and cone defects arise in rare cases of resistance to thyroid hormone ([@B39]). However, in mouse models of achromatopsia (*Pde6c* mutant) and Leber congenital amaurosis (*Rpe65* mutant) that do not originate from disrupted T3 signaling, the loss of cones at juvenile ages was reported to be partly reduced by chemically induced hypothyroidism ([@B40]) or virus-mediated overexpression of *Dio3* ([@B41]). Thus, T3 may be a secondary influence over photoreceptor degeneration caused by other factors. Deiodinases may offer a potential target for the design of interventions to ameliorate the loss of photoreceptors.

Auditory system {#s20}
---------------

The development of hearing requires T3 ([@B42]), and deafness is a risk in endemic iodine deficiency, congenital hypothyroidism ([@B43]), and resistance to thyroid hormone ([@B44]). The expression patterns of *Dio3* and *Dio2* genes in the mouse cochlea indicate that substantial control over auditory development is governed by deiodination within the auditory system ([@B7]). Our study demonstrates that deletion of *Dio2* in *Dio3*^−/−^ mice worsens rather than neutralizes the deafness in *Dio3*^−/−^ mice. Thus, in the auditory system, deiodinases do not evenly balance each other's function and may serve partly independent roles. In *Dio3*^−/−^;*Dio2*^−/−^ mice, cochlear morphology is retarded as in *Dio2*^−/−^ mice, which may be interpreted as an over-reversal of the premature differentiation in *Dio3*^−/−^ mice.

It is noteworthy that the deafness in *Dio3*^−/−^;*Dio2*^−/−^ mice is exacerbated despite circulating levels of T4 and T3 that should suffice for auditory development, implying that altered deiodination within the auditory system is a major cause of the phenotype. We speculate that the severe phenotype in *Dio3*^−/−^;*Dio2*^−/−^ mice may involve a double hit at different times or in different cell types in the auditory system. Not all defects need reside in the cochlea. T3 controls cochlear remodeling and function ([@B42]) but also promotes the maturation of auditory relay centers in the brainstem ([@B46]), in which *Dio2* mRNA is detected in rat pups ([@B47]). T3 also promotes myelination of the eighth nerve ([@B48]) and maturation of the ossicles and middle ear ([@B49]). In certain brain regions, type 2 deiodination is thought to generate T3 ([@B50]), whereas type 3 deiodination suppresses T3 responses ([@B51]). Conceivably, both processes promote the maturation of the central auditory pathway.

The cellular pathway that transfers T3 within the compartmentalized cochlea is poorly understood but presumably involves the coordinated action of deiodinases and membrane transporters for the uptake and release of T4 or T3 by specific cell types ([@B52]). However, the definition of these cell types and their anatomical proximity to cells that respond to T3 awaits improved methods for detection of deiodinases with precise cellular resolution.

Thyroid hormone status and other implications {#s21}
---------------------------------------------

In addition to tissue-intrinsic consequences of deletion of type 2 deiodinase in modifying phenotypes in *Dio3*^−/−^ mice, there may be an indirect influence of the relatively normalized systemic levels of T4 and T3. This could result from known functions of the *Dio2* gene in the hypothalamic--pituitary--thyroid axis, perhaps consistent with the rescued thyroid gland morphology in *Dio3*^−/−^;*Dio2*^−/−^ mice. Deletions in mice indicate a role for type 2 deiodinase in the anterior pituitary in the control of thyrotropin production and in the mediobasal hypothalamus in the control of thyrotropin-releasing hormone ([@B10]). In the neonatal rat hypothalamus, a rise of activating deiodination follows an earlier peak of inactivating deiodination, suggesting that functional maturation of the hypothalamic--pituitary--thyroid axis may require the balanced activities of both type 3 and type 2 deiodinases ([@B1]). Immunohistochemical studies also suggest that both deiodinases are expressed in regions of the human hypothalamus ([@B54]). However, other peripheral means may modify the systemic thyroid hormone status. Combined deletions of *Dio2* and *Dio1* ([@B56]) or of all three *Dio3*, *Dio2*, and *Dio1* deiodinase genes ([@B57]) suggest that peripheral clearance by type 1 or type 3 deiodinase modifies the levels of T4 and T3 in the circulation.

In summary, our study suggests that the composite action of the *Dio3* and *Dio2* genes is critical for visual and auditory development and for setting the thyroid hormone status. *Dio3*^−/−^ male mice also display hypogonadism that can be partly rescued by deletion of the *Dio2* gene ([@B58]). Dual patterns of *Dio3* and *Dio2* expression characterize the immature retina, cochlea ([@B7]), brain regions ([@B1]), skeletal muscle ([@B4]), and brown adipose tissue ([@B59]) in mammals and also occur in nonmammalian species ([@B60]), suggesting that together these genes provide a widely adaptable developmental mechanism.
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